Ausgabe 8/2012
Inhalt (10 Artikel)
Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management. A guideline of the TTD group
P. Pérez Segura, C. Guillén Ponce, T. Ramón y Cajal, R. Serrano Blanch, E. Aranda
Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)
R. A. Pazo-Cid, M. Lanzuela, G. Esquerdo, J. L. Pérez-Gracia, A. Antón, G. Amigo, J. Martínez Trufero, A. L. García-Otín, P. Martín-Duque
Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells
Baoshan Cao, Jun Jia, Liwen Ma, Lijun Di, Guohong Song, Yanhua Yuan, Bo Ma, Yulin Zhu, Jing Yu, Xiaoli Wang, Xinna Zhou, H. Kim Lyerly, Jun Ren
BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients
Eunice López-Muñoz, Adelina Hernández-Zarco, Normand García-Hernández, Isabel Alvarado-Cabrero, Gelasio Zarco-Espinosa, Fabio Salamanca-Gómez, Diego Arenas-Aranda
Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II–III rectal cancer
Ramon Salazar, Matilde Navarro, Ferran Losa, Vicente Alonso, Manel Gallén, Fernando Rivera, Manuel Benavides, Pilar Escudero, Encarnación González, Bartomeu Massutí, Auxiliadora Gómez, Margarita Majem, Enrique Aranda
Fifty percent patients avoid whole brain radiotherapy: stereotactic radiotherapy for multiple brain metastases. A retrospective analysis of a single center
Xiujun Chen, Jianping Xiao, Xiangpan Li, Xuesong Jiang, Ye Zhang, Yingjie Xu, Jianrong Dai
A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer
Cristina Gravalos, Antonieta Salut, Carlos García-Girón, Rocío García-Carbonero, Ana Isabel León, Isabel Sevilla, Joan Maurel, Beatriz Esteban, Eduardo García-Rico, Adolfo Murias, Hernán Cortés-Funes
Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients
Branislav Jeremić, Biljana Miličić, Slobodan Milisavljevic
Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome
Kjetil Søreide, Oddvar M. Sandvik, Jon Arne Søreide, Einar Gudlaugsson, Kjersti Mangseth, Hans Kristian Haugland